Aradhana Sarin has sold ALXN and made no open-market buys since Jun 2019
Chief Strategy, Business Off at Alexion Pharmaceuticals, Inc.
SEC CIK 0001729110 · Filings on SEC.gov ↗
$0Bought
$76KSold
NoneLast buy
Every filing
1 filing since Jun 2019, newest first
Filings come from SEC EDGAR. Not investment advice.